Created in 1949 (Germany), Adaptinol own 2081 sister brands and 17477 competing brands. The Adaptinol brand is owned by BAYER, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is DE000BAY0017. Adaptinol is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
BAYER
(Adaptinol)
over 5 years*
EUR 12.02